• Rohit Sharma MD FACS

  • Physician - Surgical Oncology


    • Marshfield - General Surgery
    • 1000 North Oak Avenue 3F1 Marshfield, WI 54449

Education

2012:
Fellowship, Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY
2010:
Research Fellowship, Oncology, Roswell Park Cancer Institute, Buffalo, NY
2008:
Residency, General Surgery, Easton Hospital, Easton, PA
2003:
Internship, General Surgery, Montefiore Medical Center, Bronx, NY
2002:
FRCS (Glas), Surgery, Royal College of Physicians and Surgeons of Glasgow, Glasgow, United Kingdom
2001:
MS, General Surgery, Lady Hardinge Medical College, New Delhi, India
2001:
FRCS (A), Surgery, Royal College of Surgeons of Edinburgh, Edinburgh, United Kingdom
1998:
BS, Chemistry, Biology, & Physics, DAV College, Amritsar, Punjab, India
1998:
Residency, General Surgery, Lady Hardinge Medical College & Hospitals, New Delhi, India
1995:
MBBS, Medicine & Surgery, Maulana Azad Medical College, New Delhi, India

Work Experience

2017 to Present:
Attending Physician, MCHS Hospitals Inc. d/b/a Marshfield Medical Center
2017 to Present:
Surgery Oncology - General Surgery, Marshfield Clinic Health System, Inc. Marshfield Medical Center - Marshfield, Marshfield, WI
2012 to 2017:
Physician, Division of Surgical Oncology, Department of Surgery, Lehigh Valley Health Network, Allentown, PA

Board Certifications

2008 to 2029:
The American Board of Surgery - General Surgery

Honors & Awards

2010:
Young Surgeon Research Competition, American College of Surgeons, Western New York Chapter, Roswell Park Cancer Institute, Buffalo, NY
2012:
Thoracic Surgery Achievement Award, Roswell Park Cancer Institute, Buffalo, NY

Presentations

2024:
Trauma, metastatic cancer, and physical abuse: Unveiling the interplay of risk factors in a nationwide analysis, Health Care Systems Research Network 2024 Conference

Select Publications

  • Gabel SA, Morrison ZD, Sharma R, Wernberg JA. Resident Participation as Co-Surgeon Does Not Adversely Impact Patient Outcomes in Pancreatic Surgery. [published online ahead of print 2020 May 23]. J Surg Educ. 77(6):1528-1533. doi: 10.1016/j.jsurg.2020.04.006.
    PubMed ID: 32457000
  • Morrison ZD, Van Steenburgh H, Gabel SA, Gabor R, Sharma R, Wernberg JA. Pancreaticoduodenectomy is safe in appropriately resourced rural hospitals. SURGERY. 2021 November;170(5):1474-1480. doi: 10.1016/j.surg.2021.04.029.
    PubMed ID: 34092374
  • Yerukala Sathipati S, Tsai MJ, Aimalla N, Moat L, Shukla SK, Allaire P,...Ho SY [including Hebbring S, Sharma R.] An evolutionary learning-based method for identifying a circulating miRNA signature for breast cancer diagnosis prediction. NAR Genom Bioinform. 2024 March;6(1):lqae022. doi: 10.1093/nargab/lqae022. PMCID: PMC10894035.
    PubMed ID: 38406797
  • Wu CC, Bassi A, Onitilo A, Sharma R. Intra-Operative Diagnosis of Benign Multicystic Peritoneal Mesothelioma: A Case Report of Rare Entity and Lessons Learned. Cureus. 2024 May 20;16(5):e60664. doi: 10.7759/cureus.60664. PMCID: PMC11186218.
    PubMed ID: 38899248
  • Sathipati SY, Jeong S, Sharma P, Mayer J, Sharma R, Ho S, Hebbring S. Exploring prognostic implications of miRNA signatures and telomere maintenance genes in kidney cancer. Molecular Therapy: Oncology. 2024 December 19;32(4):200874. doi: 10.1016/j.omton.2024.200874. PMCID: PMC11467672.
    PubMed ID: 39399813
  • Sathipati SY, Sharma R, Hebbring S. Abstract 4892: MicroRNA signature and telomere genes in kidney cancer survival. CANCER RESEARCH. 2024 March 10;84(6_Supplement):4892-4892. doi: 10.1158/1538-7445.AM2024-4892. PMCID: PMC11467672.
    PubMed ID: 39399813
  • Guenther JM, Ward A, Martin BJ, Cripe M, Sharma R, Leong SP,...Beard T. A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma. World J Surg Oncol. 2025 January 3;23(1):5. doi: 10.1186/s12957-024-03640-x. PMCID: PMC11697456.
    PubMed ID: 39754143
  • Guenther JM, Ward A, Martin BJ, Cripe M, Beard T, Wisco O,...Yamamoto M [including Sharma R.] A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEP. Cancer Med. 2025 April;14(7):e70839. doi: 10.1002/cam4.70839. PMCID: PMC11959192.
    PubMed ID: 40165762
  • Baron E, Patterson R, Tillman R, Wernberg JA, Sharma R. Real-world application of Cytalux for targeted imaging of occult peritoneal disease in epithelial ovarian cancer. Mol Clin Oncol. 2025 April 16;22(6):55. doi: 10.3892/mco.2025.2850. PMCID: PMC12035792.
    PubMed ID: 40297499